How have COVID‐19 stringency measures changed scholarly activity?

Government restrictions to the movement of people due to the COVID‐19 pandemic have had a wide range of effects on scientific activity. Here, we show that during the pandemic there has been a reduction in the number of registered non‐COVID‐19 clinical trials. Furthermore, using the Oxford COVID‐19 G...

Full description

Saved in:
Bibliographic Details
Published in:Annals of the New York Academy of Sciences 2022-07, Vol.1513 (1), p.5-9
Main Authors: Caudwell, Kim M., Soranzo, Alessandro, Lim, Lee Wei, Aquili, Luca
Format: Article
Language:English
Subjects:
Clinical trials
Clinical Trials as Topic
COVID-19
global burden of disease
government restrictions
Humans
Pandemics
Pandemics - prevention & control
research productivity
scientists
Workplace
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Government restrictions to the movement of people due to the COVID‐19 pandemic have had a wide range of effects on scientific activity. Here, we show that during the pandemic there has been a reduction in the number of registered non‐COVID‐19 clinical trials. Furthermore, using the Oxford COVID‐19 Government Response Tracker Stringency Index (SI) as an indicator of COVID‐19–related workplace adjustment (e.g., restrictions on gatherings, workplace closures, and stay‐at‐home orders), we demonstrate that this drop in clinical trial registration has been greater in countries with a higher SI. This could have significant consequences for the discovery of treatments that are required to reduce the global burden of disease. Government restrictions to the movement of people due to the COVID‐19 pandemic have had a wide range of effects on scientific activity. Here we show that during the pandemic, there has been a reduction in the number of registered non‐COVID‐19 clinical trials, which could have significant consequences for the discovery of treatments that are required to reduce the global burden of disease.
ISSN:0077-8923
1749-6632
DOI:10.1111/nyas.14767